Start: Sep 24, 2017
End: Sep 26, 2017

San Diego, CA

NOTE: The statements made in the presentations below are the authors', and do not necessarily reflect the views of, and are not endorsed by, Accuray Incorporated or its affiliates. Such statements should not be construed as medical advice.

CyberKnife Prostate
Dosimetric Verification of MLC-Collimated CyberKnife® Prostate Plans
Jacob Gersh, PhD, DABR | Gibbs Cancer Center - Spartanburg, SC
TomoTherapy Breast
Using the Tomotherapy® System for Whole Breast Irradiation in the Community Clinic Setting
Robert A. Harris, MD | Gamma West - Layton, UT
CyberKnife Pancreas
Stereotactic Body Radiotherapy for Hepatobiliary and Pancreatic Cancer
Anand Mahadevan, MD | Geisinger Health System - Danville, PA
TomoTherapy Misc
Impact of Postoperative Daily Image-Guided Intensity-Modulated Radiotherapy on Overall and Local Progression-Free Survival in Patients with Oral Cavity Cancer
Pei-Wei Shueng, MD | Far Eastern Memorial Hospital, Taiwan
TomoTherapy Adaptive
The Accuray Precision™ Treatment Planning System
Colin Sims, MSc | Accuray Incorporated
CyberKnife Misc
CyberKnife® System with Fiducial Tracking Mature Outcomes
Brian T. Collins, MD | MedStar Georgetown University Hospital - Washington, DC
Radixact Misc
Going Clinical with the Accuray Radixact™ System: The Montefiore Experience
Robert Boyd, PhD | Montefiore Medical Center - Bronx, NY
CyberKnife Misc
The Impact of 1-3 vs ≥ 4 Brain Metastases and Patient, Tumor and Imaging Parameters on Overall Survival after CyberKnife® Radiosurgery
Judith A. Murovic, MD | Stanford Medical Center - Stanford, CA
CyberKnife Prostate
CyberKnife® SBRT for Prostate Cancer: Is 5 better than 44?
Olusola Obayomi-Davies MD | Philadelphia CyberKnife/Crozer Keystone Health System - Havertown, PA
Radixact Misc
Feasibility of Real-Time Motion Management on the Radixact™ System
Eric Schnarr, PhD | Accuray Incorporated
TomoTherapy Breast
Tips and Tricks for Breast Treatment Planning with the TomoTherapy® System
Nancy Schauer, CMD | Accuray Incorporated